Scientists at The University of Texas have found out a protein that stops an enzyme that might degrade and spreading the case of cancer.

They also found that the same deactivation of the enzyme is termed EZH2 which is essential in building bones out of stem cells that make them and other tissues.

EZH2 is overly expressed as solid tumors and linked with cancer progression, and metastasis explains Mien-Chie Hung.

It was further found that another protein, CDK1, stops the activity of EZH2, Hung explained.

The findings further clear path for developing an EZH2 inhibitor or a drug that replicates the protein that neutralizes the new cancer drugs.

EZH2 plays a vital role in a diverse role of biological processes. "EZH2 is crucial to embryonic development because it turns genes off and on to guide the differentiation of embryonic stem cells into tissues and organs," Hung said.